A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04495933 |
Recruitment Status :
Active, not recruiting
First Posted : August 3, 2020
Last Update Posted : August 27, 2021
|
Sponsor:
The University of Queensland
Collaborators:
Syneos Health
Coalition for Epidemic Preparedness Innovations
Information provided by (Responsible Party):
The University of Queensland
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | November 6, 2021 |
Estimated Study Completion Date : | February 2, 2022 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):